Scott T. Aaronson, MD

Articles by Scott T. Aaronson, MD

©Adike/Shutterstock

We have medications that can affect serotonin, norepinephrine, and-to a lesser extent-dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.

Latest Updated Articles